Norepinephrine Hameln (Noradrenaline Tartrate)

Noradrenaline Tartrate, the active ingredient in Norepinephrine Hameln, is an adrenergic agonist presented as an injectable solution for intravenous administration. It is employed to raise blood pressure and improve cardiac output in patients experiencing severe hypotension, septic shock, or cardiogenic shock, typically in intensive care settings.

GNH USA supplies Norepinephrine Hameln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. All batches are manufactured under EU GMP guidelines and undergo rigorous quality testing before release.

Norepinephrine Hameln is used as a vasopressor to support circulatory function in critical care.

Hypotension: Restores arterial pressure and organ perfusion in patients with acute low blood pressure. Septic shock: Increases systemic vascular resistance to improve blood pressure and tissue perfusion during severe infection. Cardiogenic shock: Enhances cardiac output and maintains coronary perfusion in patients with pump failure.

Norepinephrine Hameln may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Tachycardia - Arrhythmia - Headache - Nausea - Peripheral ischemia

Serious or Rare Side Effects: - Severe hypertension - Myocardial ischemia - Tissue necrosis at extravasation site - Pulmonary edema

When using Norepinephrine Hameln, clinicians should observe several safety measures to minimize risks.

Blood pressure monitoring: Continuously assess arterial pressure to titrate infusion. Cardiac rhythm monitoring: Observe for arrhythmias, especially in patients with pre‑existing heart disease. Extravasation risk: Administer via a central venous catheter and stop infusion immediately if infiltration occurs. Dose titration: Adjust infusion slowly to avoid abrupt changes in hemodynamics. Use with caution in myocardial ischemia: Reduced coronary perfusion may worsen injury. Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine Hameln can interact with other agents that affect the sympathetic nervous system or vascular tone.

Major Interactions (Avoid): - MAO inhibitors: Potentiate vasoconstrictive effects, risking severe hypertension. - β‑blockers: May blunt the intended increase in heart rate and cardiac output. - Tricyclic antidepressants: Enhance norepinephrine activity, increasing risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin): May counteract pressor effect, requiring dose adjustments. - ACE inhibitors: Can augment hypotensive episodes if norepinephrine is tapered abruptly. - Diuretics: May affect intravascular volume, influencing response to the drug. - Calcium channel blockers: May have additive effects on blood pressure control.